Beneficial effects of dantrolene on lipopolysaccharide-induced haemodynamic alterations in rats and mortality in mice

European Journal of Pharmacology

Volumn 327, Issue 1, 1997, Pages 17-24

  Wu, Chin Chen ^a   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Dantrolene; Hemodynamic alteration; Lipopolysaccharide; Mortality; Nitric oxide (NO) synthase II

Indexed keywords

DANTROLENE; LIPOPOLYSACCHARIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANESTHESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE;

EID: 0030908299     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)89673-2     Document Type: Article

References (47)

1. Bigaud M., Julou-Schaeffer G., Parratt J.R., Stoclet J.C. Endotoxin-induced impairment of vascular smooth muscle contractions elicited by different mechanisms. Eur. J. Pharmacol. 190:1990;185-192.
2. Bohr D.F. Dual effects of calcium. Science. 139:1963;597-599.
3. Bosson S., Kuenzig M., Swartz S.I. Verapamil improves cardiac function and increases survival in canine E. coli endotoxin shock. Circ. Shock. 16:1985;307-316.
4. Casado M., Diaz-Guerra M.J.M., Bosca L., Martin-Sanz P. Characterization of nitric oxide dependent changes in carbohydrate hepatic metabolism during septic shock. Life Sci. 58:1996;561-572.
5. Chaudry I.H., Wichterman K.A., Baue A.E. Effect of sepsis on tissue adenine nucleotide levels. Surgery. 85:1979;205-211.
6. Chen S.J., Wu C.C., Yen M.H. Alterations of ex vivo vascular reactivity in intraperitoneal sepsis. J. Cardiovasc. Pharmacol. 24:1994;786-793.
7. Chernow B., Rainey T.G., Lake C.R. Endogenous and exogenous catecholamines in critical care medicine. Crit. Care Med. 10:1982;409-416.
8. Ellis K.O., Bryant S.H. Excitation-contraction uncoupling in skeletal muscle by dantrolene sodium. Naunyn-Schmiedeberg's Arch. Pharmacol. 274:1972;107-109.
9. Fink M.D., Homer L.D., Flechter J.R. Diminished pressor responses to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. J. Surg. Res. 38:1985;335-342.
10. Fleming I., Gray G.A., Julou-Schaeffer G., Parratt J.R., Stoclet J.C. Incubation with endotoxin activates the L-arginine pathway in vascular tissue. Biochem. Biophys. Res. Commun. 171:1990;562-568.
11. Gray G.A., Julou-Schaeffer G., Oury K., Fleming I., Parratt J.R., Stoclet J.C. An L-arginine-derived factor mediates endotoxin-induced vascular hyposensitivity to calcium. Eur. J. Pharmacol. 191:1990;89-92.
12. Gray G.A., Schott C., Julou-Schaeffer G., Fleming I., Parratt J.R., Stoclet J.C. The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats. Br. J. Pharmacol. 103:1991;1218-1224.
13. Hainaut K., Desmedt J.E. Effect of dantrolene sodium on calcium movements in single muscle fibres. Nature. 252:1974;728-729.
14. G-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem. Biophys. Res. Commun. 172:1990;1132-1138.
15. Lee H.C., Lum B.K.B. Protective action of calcium entry blockers in endotoxin shock. Circ. Shock. 18:1986;193-203.
16. Lee H.C., Hardman J.H., Lum B.K.B. The effects of the calcium entry blockers, nivaldipine and nitrendipine, on endotoxin-induced disseminated intravascular coagulation. Life Sci. 45:1989;877-883.
17. Lin J.H., Lin M.T. Nitric oxide synthase-cyclo-oxygenase pathways in organum vasculosum laminae terminalis: possible role in pyrogenic fever in rabbits. Br. J. Pharmacol. 118:1996;179-185.
18. Litten R.Z., Carcillo J.A., Roth B.L. Alterations in bidirectional transmembrane calcium flux occur without changes in protein kinase C levels in rat aorta during sepsis. Circ. Shock. 25:1988;123-130.
19. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Selectivity of nonsteroidal anti-inflammatory dugs as inhibitors of constitutive and inducible cyclo-oxygenase. Proc. Natl. Acad. Sci. USA. 90:1993;11693-11697.
20. Moncada S., Higgs A. The L-arginine-nitric oxide pathway. New Engl. J. Med. 329:1993;2002-2012.
21. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
22. Mozes T., Van Gelderen E.M., Mylecharane E.J., Saxena P.R. Beneficial haemodynamic effect of indomethacin during endotoxin shock in anaesthetized pigs: putative involvement of nitric oxide? Mediators Inflamm. 4:1995;117-123.
23. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
24. 2+ pool depletion is linked to the induction of nitric oxide synthesis in murine peritoneal macrophages. Biochem. Mol. Biol. Int. 36:1995;949-955.
25. Parratt, J.R., 1989. Alterations in vascular reactivity in sepsis and endotoxaemia. In: Vincent, J.L. (Ed.), Update in Intensive Care and Emergency Medicine. Springer, Berlin, pp. 299-308.
26. Pomerantz K., Casey L., Fletcher J.R., Ramwell P.W. Vascular reactivity in endotoxin shock: effect of lidocaine or indomethacin pretreatment. Adv. Shock Res. 7:1982;191-198.
27. Rees D.D., Cellek S., Palmer R.M.J., Moncada S. Dexamethasone prevents the induction of a nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock. Biochem. Biophys. Res. Commun. 173:1990;541-547.
28. Rosenberg, H., Fletcher, J.E., 1987. Malignant hyperthermia. In: Azar, L. (Ed.), Muscle Relaxants: Side Effects and a Rational Approach to Selection. Marcel Dekker, New York, NY, pp. 115-148.
29. Sakaguchi S., Abe H., Sakaguchi O. Calcium behavior in endotoxin-poisoned mice: especially calcium accumulation in mitochondria. Microbiol. Immunol. 28:1984;517-527.
30. Sayeed M.M., Maitra S.R. Effect of diltiazem on intracellular calcium regulation during endotoxic shock. Am. J. Physiol. 253:1987;R545-R548.
31. Schaller M.D., Waeber G., Nussberger J., Brunner J.R. Angiotensin II, vasopressin and sympathetic activity in conscious rat with endotoxemia. Am. J. Physiol. 249:1985;H1086-H1092.
32. Siegel J.H., Cerra F.B., Coleman B. Physiological and metabolic correlations in human sepsis. Surgery. 86:1979;163-193.
33. Szabo C., Thiemermann C. Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv. Pharmacol. 34:1995;113-153.
34. Szabo C., Mitchell J.A., Gross S.S., Thiemermann C., Vane J.R. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J. Pharmacol. Exp. Ther. 256:1993;674-680.
35. Szabo C., Mitchell J.A., Thiemermann C., Vane J.R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol. 108:1993;786-792.
36. Thiemermann C. The role of the L-arginine : nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28:1994;45-79.
37. Thiemermann C., Vane J.R. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat in vivo. Eur. J. Pharmacol. 182:1990;591-595.
38. Thiemermann C., Wu C.C., Szabo C., Perretti M., Vane J.R. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br. J. Pharmacol. 110:1993;177-182.
39. Van Breemen C., Chen Q., Laher I. Superficial buffer barrier function of smooth muscle sarcoplasmic reticulum. Trends Pharmacol. Sci. 16:1995;98-105.
40. Van Breemen C., Leekeman S., Leijten P., Yamamoto H., Loutzenhiser R. The role of superficial SR in modulating force development induced by Ca entry into arterial smooth muscle. J. Cardiovasc. Pharmacol. Suppl. 8:1986;S111-S116.
41. Van Winkle W.B. Calcium release from skeletal muscle sarcoplasmic reticulum: site of action of dantrolene sodium? Science. 193:1976;1130-1131.
42. Van Zwieten P.A., Pfaffendorf M. Similarities and differences between calcium antagonists: pharmacological aspects. J. Hypertens. 11(Suppl. 1):1993;S3-S11.
43. Wakabayashi I., Hatake K., Kakishita E., Nagai K. Diminution of contractile response of the aorta from endotoxin-injected rats. Eur. J. Pharmacol. 141:1987;117-122.
44. Wakabayashi I., Kakishita E., Hatake K., Hishida S., Nagai K. Effect of phorbol ester on contractile response of aorta from endotoxic rats. Biochem. Biophys. Res. Commun. 150:1988;1115-1125.
45. Wright C.E., Rees D.D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc. Res. 26:1992;48-57.
46. Wu C.C., Chen S.J., Szabo C., Thiemermann C., Vane J.R. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br. J. Pharmacol. 114:1995;1666-1672.
47. ω-nitro-L-arginine methyl ester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur. J. Pharmacol. 300:1996;99-104.